Twist Bioscience (TWST)

• Market cap: $2.46B
• 1 day: -8.36%
• 5 days: -13.03%
• 1 month: -18.12%
• 3 months: -0.84%
• 6 months: -6.39%
• Year to date: -8.83%
• 1 year: 7.69%
• 5 years: 24.99%
• 10 years: 195.07%
• Sector: Healthcare
• Industry: Biological Products, Except Diagnostic Substances

About: Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

Employees: 923

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

196% more call options, than puts

Call options by funds: $5.99M | Put options by funds: $2.02M

100% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 2 (+1) [Q4]

23% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 26

9% more repeat investments, than reductions

Existing positions increased: 89 | Existing positions reduced: 82

0% more funds holding

Funds holding: 243 [Q3] → 244 (+1) [Q4]

0% less capital invested

Capital invested by funds: $3.09B [Q3] → $3.08B (-$8.25M) [Q4]

5.25% less ownership

Funds ownership: 116.7% [Q3] → 111.46% (-5.25%) [Q4]

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $40 3% downside
• Avg. target: $55 33% upside
• High target: $62 50% upside

5 analyst ratings

• positive: 4 80%
• neutral: 0 0%
• negative: 1 20%

Scotiabank Sung Ji Nam 39% 1-year accuracy 9 / 23 met price target	50% upside $62	Sector Outperform Maintained	4 Feb 2025
JP Morgan Rachel Vatnsdal 65% 1-year accuracy 11 / 17 met price target	3% downside $40	Underweight Maintained	4 Feb 2025
Baird Catherine Ramsey 77% 1-year accuracy 10 / 13 met price target	31% upside $54	Outperform Maintained	4 Feb 2025
Wolfe Research Doug Schenkel 20% 1-year accuracy 1 / 5 met price target	45% upside $60	Outperform Initiated	13 Dec 2024
TD Cowen Steven Mah 60% 1-year accuracy 3 / 5 met price target	40% upside $58	Buy Reiterated	26 Nov 2024